- PR Newswire•4 days ago
MARLBOROUGH, Mass., Feb. 15, 2017 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active HCV infection on the fully automated Panther® system. "HCV therapeutic options continue to evolve rapidly with highly effective antiviral medications that are transforming treatment of the disease, with cure rates above 90%," said Tom West, president, Diagnostic Solutions Division at Hologic.
- Investopedia•4 days ago
Hologic is acquiring Cynosure to expand into the growing medical aesthetics field.
- Zacks•4 days ago
Cynosure, Inc. (CYNO), announced that it has entered into a definitive merger agreement with Hologic, Inc. (HOLX).
HOLX : Summary for Hologic, Inc. - Yahoo Finance
Hologic, Inc. (HOLX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||39.95 x 200|
|Ask||42.33 x 100|
|Day's Range||39.21 - 40.01|
|52 Week Range||32.64 - 41.24|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||34.19|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|